Global collaboration between platform trials in surgery and anaesthesia
Open Access
- 27 November 2024
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (12)
Abstract
Summary: Large, randomized trials are the bedrock of evidence-based medicine, but the resources required to complete such trials greatly limit the number of important clinical questions that can be addressed within a reasonable period of time. Adaptive platform trials can identify effective, ineffective, or harmful treatments faster. These trials have been shown to deliver rapid evidence through the COVID-19 pandemic and are now being adopted across surgery and anaesthesia, with many opportunities for surgeons, anaesthetists, and other perioperative physicians to conduct and collaborate in platform trials.Keywords
Funding Information
- National Health and Medical Research Council (2008079, 2033294)
- Victorian Medical Research Acceleration Fund (GA-F4668961-1110)
- National Institute for Health and Care Research
- Health Technology Assessment (16/31/123, NIHR160509, NIHR163832)
- NIHR
- National Health Service
- Department of Health and Social Care
This publication has 21 references indexed in Scilit:
- Association between postoperative complications and lingering post-surgical pain: an observational cohort studyBritish Journal of Anaesthesia, 2020
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or BothNew England Journal of Medicine, 2017
- When clinical trials compete: prioritising study recruitmentJournal of Medical Ethics, 2017
- Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countriesBritish Journal of Anaesthesia, 2016
- Pragmatic TrialsNew England Journal of Medicine, 2016
- Mortality of emergency abdominal surgery in high-, middle- and low-income countriesBritish Journal of Surgery, 2016
- The Platform TrialJAMA, 2015
- Adaptive clinical trials in oncologyNature Reviews Clinical Oncology, 2011
- Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi‐arm, multistage randomized controlled trialBJU International, 2009
- Surgical research or comic opera: questions, but few answersThe Lancet, 1996